Xtant Medical Holdings, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Xtant Medical Holdings, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2023.
  • Xtant Medical Holdings, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $25.8M, a 24% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $25.8M +$5M +24% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $20.8M +$1.51M +7.84% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $19.3M +$314K +1.66% Dec 31, 2021 10-K 2023-03-07
Q4 2020 $19M -$11M -36.6% Dec 31, 2020 10-K 2022-03-08
Q4 2019 $29.9M +$73K +0.24% Dec 31, 2019 10-K 2021-02-24
Q4 2018 $29.9M +$7.27M +32.2% Dec 31, 2018 10-K 2020-03-05
Q4 2017 $22.6M +$6.39M +39.5% Dec 31, 2017 10-K 2019-04-01
Q4 2016 $16.2M +$3.13M +24% Dec 31, 2016 10-K/A 2018-04-05
Q4 2015 $13.1M Dec 31, 2015 10-K 2017-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.